Don't use DIABETES as a CV risk equivalent
As a pharmacy doctor, you will see more consensus on using statins for diabetes patients.…
Personalize glycemic targets for patients with diabetes
As a clinical pharmacist, people with diabetes will rely on your help to tailor A1c goals…
Think "LOWER IS BETTER" for LDL in high CV risk patients
Overview As a cardiovascular pharmacist, there is an ongoing debate regarding the nece…
Answer questions about INSULIN for type 2 diabetes
As a clinical pharmacist, you can help answer questions about how to use insulin for pati…
Finerenone (Kerendia) role for Diabetic Kidney Disease
As a hospital pharmacist, you will hear about a new medication finerenone ( Kerendia ) f…
Optimize management of CKD in patients with diabetes
As a clinical pharmacist, you should optimize treatment of chronic kidney disease (CKD) i…
Explaining the role of Mounjaro for Type 2 Diabetes
Mounjaro (Tirzepatide): A Novel Approach for Type 2 Diabetes Management As a pharmacy …
Treatment of inpatient HYPERglycemia
New data will fuel debate about sliding scale insulin for inpatient hyperglycemia in pat…
Insulin resistance is a BIG problem
Metabolic syndrome is a BIG problem and growing. It affects over 25% of adults and 4% of …
Wegovy for weight loss
Overview As a nutrition support pharmacist, you’re likely hearing a lot about Wegovy …
Dispense SAXENDA for weight loss
As a community pharmacist, you will hear about using Saxenda for weight loss. Saxenda (l…
Reduce insulin if SAXENDA is used for weight loss
Overview As a nutrition support pharmacist, you will hear more about using Saxenda f…
Update HYPOglycemia prevention strategies
Harmful hypoglycemic events are still occurring in hospitals. Continue to utilize strateg…
Compare medications for DIABETIC Neuropathy
Overview Up to 50% of patients with diabetes develop peripheral neuropathy. Tailor medi…